Skip to main content
. 2025;37(4):276–280. doi: 10.5455/msm.2025.37.276-280

Table 2. Distribution of DARC genotypes among the study population.

Genotype Patients
N (%)
Control
N (%)
P.value
FYB / FYB 24 (11.9%) 7 (03.4%) 0.005
FYA / FYA 10 (05.0%) 5 (02.5%) >0.25
FYBES/ FYBES 43 (21.3%) 100 (49.2%) <0.001*
FYB / FYA 32(15.8%) 3 (01.5%) <0.001*
FYB / FYBES 65 (32.0%) 59 (29.1%) <0.05*
FYA /FYBES 28 (13.9%) 29 (14.3%) >0.5